Bill Adams

Bill Adams

Keine laufenden Positionen mehr

Vermögen: 322 547 $ am 31.05.2026

64 Jahre
Health Technology
Finance
Consumer Services

Profil

William J.
Adams
worked as a Lending Officer at Mellon Bank, NA in 1993.
From 1994 to 1996, worked as a Securities Analyst at Conseco Life Insurance Company of Texas.
Served as Portfolio Manager at Massachusetts Financial Services Co. from 2000 to 2005.
Held the position of Chief Financial Officer, Secretary & Treasurer at AnorMED, Inc. from 1997 to 2006.
Was Chief Financial Officer at CellFor, Inc. from 2008 to 2010.
Served as Chief Financial Officer at Response Biomedical Corp.
in 2012.
Worked as Chief Investment Officer of Global Fixed Income at Massachusetts Financial Services Co. from 2015 to 2024.
Held the role of Chief Financial Officer & Secretary at NervGen Pharma Corp.
from 2020 to 2026.
Also served as Chief Financial Officer at Anandia Laboratories, Inc. Education includes an undergraduate degree from the University of British Columbia in 1988, a graduate degree from Indiana University in 1990, and an MBA from Indiana University in 1991.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
14.03.2025 155.820 ( 0,19 % ) 322 547 $ 31.05.2026

Ehemalige bekannte Positionen von Bill Adams

UnternehmenPositionEnde
NERVGEN PHARMA CORP. Finanzdirektor/CFO 15.03.2026
Forschungsdirektor - Fxd Inc 01.01.2011
Finanzdirektor/CFO 29.04.2010
Finanzdirektor/CFO 09.11.2006
Portfolio Manager-Fixed Income 01.01.2005
Sehen Sie sich die Erfahrung von Bill Adams im Detail an

Ausbildung von Bill Adams

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

96

Beziehungen ersten Grades

10

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen10

Finance

Finance

Health Technology

Health Technology

Consumer Services

Consumer Services

Process Industries

Finance

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Bill Adams